| Ferroptosis and cancer prognosis | Lifetime | 137 | CN 57 | 98.04 |
| Pharmacological Effects of Natural Compounds | Lifetime | 463 | CN 129 | 96.96 |
| Traditional Chinese Medicine Analysis | Lifetime | 192 | CN 150 | 96.99 |
| Autophagy in Disease and Therapy | Lifetime | 485 | CN 76 | 96.90 |
| Natural product bioactivities and synthesis | Lifetime | 624 | CN 142 | 97.38 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 795 | CN 51 | 97.52 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 432 | CN 39 | 96.60 |
| Berberine and alkaloids research | Lifetime | 116 | CN 37 | 94.90 |
| Tryptophan and brain disorders | Lifetime | 882 | CN 32 | 96.31 |
| Traditional Chinese Medicine Studies | Lifetime | 353 | CN 217 | 92.94 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 870 | CN 39 | 94.56 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 461 | CN 76 | 92.22 |
| Ginseng Biological Effects and Applications | Lifetime | 922 | CN 450 | 89.18 |
| Bioactive natural compounds | Lifetime | 668 | CN 133 | 85.42 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 514 | CN 160 | 81.57 |
| Ginkgo biloba and Cashew Applications | Lifetime | 647 | CN 93 | 81.25 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 913 | CN 476 | 70.07 |
| Natural Compounds in Disease Treatment | Lifetime | 774 | CN 403 | 64.91 |
| Andrographolide Research and Applications | Lifetime | 589 | CN 155 | 51.74 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 29 | CN 4 | 99.11 |
| Ferroptosis and cancer prognosis | 2021-2025 | 52 | CN 37 | 98.87 |
| Tryptophan and brain disorders | 2021-2025 | 37 | CN 7 | 98.65 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 8 | CN 6 | 98.72 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 14 | CN 4 | 97.81 |
| Berberine and alkaloids research | 2021-2025 | 3 | CN 2 | 96.12 |
| Autophagy in Disease and Therapy | 2021-2025 | 54 | CN 24 | 97.40 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 16 | CN 3 | 95.28 |
| Natural product bioactivities and synthesis | 2021-2025 | 84 | CN 43 | 95.48 |
| Alzheimer's disease research and treatments | 2021-2025 | 221 | CN 12 | 97.54 |
| RNA modifications and cancer | 2021-2025 | 933 | CN 635 | 93.74 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 143 | CN 10 | 91.08 |
| MicroRNA in disease regulation | 2021-2025 | 794 | CN 486 | 92.29 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 250 | CN 68 | 92.08 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 143 | CN 44 | 89.50 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 296 | CN 179 | 89.03 |
| Biochemical effects in animals | 2021-2025 | 147 | CN 98 | 90.12 |
| Mitochondrial Function and Pathology | 2021-2025 | 832 | CN 112 | 86.98 |
| Stress Responses and Cortisol | 2021-2025 | 636 | CN 74 | 86.72 |
| Ginseng Biological Effects and Applications | 2021-2025 | 395 | CN 330 | 80.19 |
| Clinical practice guidelines implementation | 2021-2025 | 548 | CN 39 | 74.89 |
| Cancer Mechanisms and Therapy | 2021-2025 | 808 | CN 359 | 73.99 |
| Chromatography in Natural Products | 2021-2025 | 213 | CN 114 | 73.56 |
| Vagus Nerve Stimulation Research | 2021-2025 | 372 | CN 75 | 71.81 |
| Traditional Chinese Medicine Studies | 2021-2025 | 415 | CN 306 | 69.64 |
| Acupuncture Treatment Research Studies | 2021-2025 | 778 | CN 520 | 70.06 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 809 | CN 118 | 67.63 |
| S100 Proteins and Annexins | 2021-2025 | 685 | CN 133 | 65.80 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 660 | CN 223 | 64.88 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 297 | CN 122 | 63.41 |
| Kruppel-like factors research | 2021-2025 | 470 | CN 181 | 63.72 |
| Signaling Pathways in Disease | 2021-2025 | 548 | CN 223 | 58.90 |
| Plant chemical constituents analysis | 2021-2025 | 214 | CN 70 | 55.67 |
| Plant-based Medicinal Research | 2021-2025 | 597 | CN 416 | 51.14 |
